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Summary
Intrauterine undernutrition is closely associated with obesity related to detrimental metabolic sequelae in adulthood. We
report a mouse model in which offspring with fetal undernutrition (UN offspring), when fed a high-fat diet (HFD), develop
pronounced weight gain and adiposity. In the neonatal period, UN offspring exhibited a premature onset of neonatal
leptin surge compared to offspring with intrauterine normal nutrition (NN offspring). Unexpectedly, premature leptin surge
generated in NN offspring by exogenous leptin administration led to accelerated weight gain with an HFD. Both UN
offspring and neonatally leptin-treated NN offspring exhibited an impaired response to acute peripheral leptin administra-
tion on a regular chow diet (RCD) with impaired leptin transport to the brain as well as an increased density of hypothala-
mic nerve terminals. The present study suggests that the premature leptin surge alters energy regulation by the hypothala-
mus and contributes to “developmental origins of health and disease.”Introduction
Obesity has increased at an alarming rate in Western countries
and is now a world-wide public health problem (Flier, 2004).
Obesity is often associated with insulin resistance, dyslipide-
mia, and hypertension, thus a concept of metabolic syndrome
has been proposed (Masuzaki et al., 2001; Wajchenberg,
2000). Genetic factors and/or environmental factors, such as
high-calorie diet in Western life style, have been considered to
attribute to the prevalence of obesity (Flier, 2004). More re-
cently, epidemiological and experimental evidence suggest
that intrauterine undernutrition is closely associated with adult-
hood obesity related to detrimental metabolic sequelae (Breier
et al., 2001; Godfrey and Barker, 2000; Ravelli et al., 1976),
giving rise to the concept of “developmental origins of health
and disease” (Breier et al., 2001; Gluckman and Hanson, 2004).
Involvement of perinatal exposure to glucocorticoids or pan-
creatic maldifferentiation in the development of impaired glu-
cose metabolism has been demonstrated (Breier et al., 2001;
Gluckman and Hanson, 2004). However, the mechanism of de-
velopmental origins of obesity is yet to be clarified.
Leptin is an adipocyte-derived satiety factor that decreases
food intake and increases energy expenditure, thereby stabiliz-
ing body adiposity in many species (Friedman and Halaas,
1998). Leptin deficient ob/ob mice show marked obesity that is
restored by exogenous leptin treatment (Campfield et al., 1995;
Halaas et al., 1995; Pelleymounter et al., 1995; Trayhurn et al.,
1977). Leptin exerts its biological activities through long-form
leptin receptors, expressed abundantly in the hypothalamusCELL METABOLISM : JUNE 2005 · VOL. 1 · COPYRIGHT © 2005 ELSEV(Flier, 2004). However, resistance to the satiety effect of leptin
is a trait of obese subjects, as circulating leptin levels are well
correlated with body fat mass (Ahren and Scheurink, 1998). It
remains to be elucidated whether leptin resistance at the hypo-
thalamus is associated with the onset of obesity or metabolic
disorders in offspring with intrauterine growth restriction.
In mice, plasma leptin levels rise transiently during neonatal
period, termed as “neonatal leptin surge” (Ahima et al., 1998).
In neonatal period, leptin alters hypothalamic neuropeptide ex-
pression and metabolic rate before exerting its anorectic effect
(Ahima and Hileman, 2000; Mistry et al., 1999; Proulx et al.,
2002). Moreover, neurotrophic action of leptin was recently
demonstrated, which is operative only in early developmental
stage, but not in adult individuals (Bouret et al., 2004a; Bouret
et al., 2004b). Therefore, it is suggested that leptin surge is
involved in the formation of energy-regulation circuits in the
hypothalamus. However, long-term effects of physiological or
pathophysiological leptin surge on hypothalamic neuronal cir-
cuits are yet to be fully clarified. Here, we demonstrate a
mouse model of intrauterine undernutrition in which premature
leptin surge contributes to developmental origins of obesity.
Results and discussion
Development of obesity and related metabolic disorders
in offspring with intrauterine undernutrition
Maternal body weight gain during pregnancy was significantly
suppressed by 30% restriction of maternal food supply (FigureIER INC. DOI 10.1016/j.cmet.2005.05.005 371
A R T I C L EFigure 1. Exaggerated diet-induced weight gain in
offspring with fetal undernutrition (UN) compared to
offspring with normal fetal nutrition (NN)
A) Maternal body weight change during pregnancy.
Food restriction started on day 10.5 postcoitum as
described in the Experimental Procedures. Number
of dams in each group is seven to eight.
B) Fetal weights at 18.5 d.p.c. in three litters in both
groups. Weights of both male and female fetuses
were plotted without discrimination. Litter sizes of
demonstrated litters are nine to ten in both NN
group and UN group.
C) Neonatal catch-up growth in UN offspring. n =
96 from 12 litters for each group. Average body
weights of 96 pups including both male and female
pups in each group are shown.
D) Exaggerated weight gain in UN offspring on an
HFD but not on an RCD. HFD was started at 9
weeks of age.
E) Plasma leptin concentrations at 17 weeks of age.
Dark and light purple lines (A, C, and D), dots (B)
and columns (E) indicate dams or offspring with un-
dernutrition. *p < 0.05 versus NN offspring; n.s.: not
significant. In the experiment for (D) and (E), all pups
were nursed at a rate of 8 pups per dam until wean-
ing. Only male animals were used for further experi-
ments. n = 7–15 for each group in (D) and (E).
Error bars represent SEM.1A). The UN offspring were born small (Figure 1B) with reduced
lipid accumulation in the subcutaneous adipose tissue (data
not shown) but caught up in body weight to NN offspring within
10 days after birth (Figure 1C). They showed no apparent dif-
ference in body weight and fat mass on an RCD thereafter (Fig-
ure 1D; Table 1). However, UN offspring developed pronounced
weight gain and adiposity (40% and 30% larger in subcutane-
ous and epididymal fat depots, respectively) compared to NN
offspring, when fed a HFD commencing at 9 weeks of age (Fig- spring with regard to calorie intake during the development of
Table 1. Adiposity and lipid profiles of NN and UN offspring
NN Offspring UN Offspring
RCD HFD RCD HFD
(n = 15) (n = 13) (n = 7) (n = 11)
Body mass index (g/cm2) 0.33 ± 0.01 0.37 ± 0.01 0.31 ± 0.01 0.42 ± 0.01a
Subcutaneous adipose tissue (g) 0.52 ± 0.05 1.12 ± 0.10 0.42 ± 0.04 1.67 ± 0.14a
Epididymal adipose tissue (g) 0.58 ± 0.06 1.50 ± 0.15 0.48 ± 0.05 1.98 ± 0.09b
Leptin mRNA expression in subcutaneous adipose tissue (AU) 2.84 ± 0.69 26.26 ± 5.28 2.99 ± 0.46 21.39 ± 4.54
Serum triglyceride (mg/dl) 192.1 ± 18.2 199.6 ± 20.2 134.8 ± 9.2a 125.0 ± 10.9a
Serum total cholesterol (mg/dl) 101.3 ± 4.0 166.3 ± 16.9 92.6 ± 5.2 222.0 ± 5.8a
Serum HDL cholesterol (mg/dl) 47.6 ± 7.0 97.7 ± 12.7 54.0 ± 5.9 132.7 ± 6.5b
Serum free fatty acids (mg/dl) 0.61 ± 0.04 0.75 ± 0.06 0.69 ± 0.06 0.50 ± 0.00b
Samples are collected from offspring with normal intrauterine nutrition (NN) and from offspring with intrauterine undernutrition (UN) on an RCD or on an HFD at 17
weeks of age.
Differences between RCD group and HFD group were not demonstrated in both groups.
ap < 0.01 versus NN offspring.
bp < 0.05 versus NN offspring.372ure 1D; Table 1). An obesity-prone phenotype of UN offspring
was confirmed in an additional three independent experiments.
Serum leptin levels in UN offspring were significantly higher
than those in NN offspring on an HFD (p < 0.05), in parallel
with their adiposity (Figure 1E; Table 1). These observations are
in agreement with previous reports on rodent models of fetal
undernutrition and catch-up growth (Ozanne and Hales, 2004)
The UN offspring did not differ significantly from NN off-CELL METABOLISM : JUNE 2005
Premature leptin surge in development of obesityFigure 2. Blunted diet-induced thermogenesis and impaired glucose metabolism
in UN offspring compared to NN offspring
A) Average daily calorie intake from 9 to 17 weeks of age on an RCD or on an
HFD in NN and UN offspring. n = 7–15.
B) Resting rectal body temperature, (C) O2 consumption, and (D) CO2 production
were measured in NN and UN offspring on an RCD or on an HFD at 13 weeks of
age. n.s.: not significant. n = 7–15.
E) Glucose tolerance test was performed at 17 weeks of age on an RCD.
F and G) Insulin sensitivity was examined at 19 weeks of age on an RCD (F) and
on an HFD (G). Initial glucose levels of UN and NN offspring were 100.5 ± 3.3
and 109.3 ± 5.8 mg/dl in (E), 95.5 ± 3.3 and 113.0 ± 4.9 mg/dl in (F), and 186 ±
14.8 and 157.1 ± 8.3 mg/dl in (G), respectively. #p < 0.05 versus NN offspring.
n = 6–11 in another series of experiments from that in (A–D).
Dark and light purple columns (A, B, C, and D) and lines (E, F, and G) indicate
UN offspring. Error bars represent SEM.diet-induced weight gain (Figure 2A). On an HFD, NN offspring
showed elevated rectal temperature and increased O2 con-
sumption and CO2 production (Figures 2B–2D). On the other
hand, UN offspring did not show such changes in energy me-
tabolism, suggesting impaired diet-induced thermogenesis
(DIT; Lowell and Spiegelman, 2000). These characteristics of
energy metabolism in UN offspring are consistent with the
“thrifty phenotype hypothesis” according to which undernutri-CELL METABOLISM : JUNE 2005tion in utero programs offspring to conserve energy for survival
under conditions of scarce food supply after birth (Hales and
Barker, 2001). A significant elevation of uncoupling proteins’
(UCP-1 and -2) mRNA expression in the brown adipose tissue
(BAT) of both UN and NN offspring on an HFD (data not shown)
could not explain clearly the mechanisms of blunted diet-
induced thermogenesis in UN offspring. Nonetheless, an HFD
significantly augmented free fatty acid (FFA) concentrations in
NN offspring, but not in UN offspring (Table 1). Since the re-
lease of FFA from WAT stimulates mitochondrial thermogenesis
in BAT (Ricquier and Bouillaud, 2000), altered lipid metabolism,
such as low FFA levels in UN offspring, may partly contribute
to the blunted diet-induced thermogenesis in these animals.
The UN offspring also showed impaired glucose metabolism
and lipid profiles compared to NN offspring (Figures 2E and 2F;
Table 1). HFD deteriorated an impairment of both glucose (Fig-
ure 2G) and lipid metabolism (Table 1). These findings indicate
that intrauterine undernutrition in the present study is an appro-
priate model for the elucidation of fetal origins of metabolic
syndrome.
Neonatal premature leptin surge is associated
with obesity
During the catch-up growth, the peak of leptin surge, a tran-
sient rise of serum leptin levels in mice neonates (Ahima et
al., 1998) was advanced (8–10 days after birth) in UN offspring
compared to that in NN offspring (16 days after birth; Figure
3A). Profiles of neonatal leptin concentrations in UN and NN
offspring were fundamentally parallel with leptin mRNA expres-
sion in subcutaneous adipose tissue (Figure 3B), suggesting
that altered leptin production is responsible for premature on-
set of leptin surge. UN offspring showed hyperglycemia and
hyperinsulinemia at 8 days of age (data not shown). Increase in
insulin signal augments leptin production from adipose tissue
(Considine, 2001). It is likely that intrauterine undernutrition in-
duced, at least partly through altered glucose metabolism, pre-
mature leptin surge in these offspring. According to Ahima et
al. (1998), the timing for the leptin surge in mice not subjected
to intrauterine undernutrition is day 10, while we observed a
peak leptin surge occurring at day 16. The discrepancy might
be due to differences in number of pups in each litter, i.e., only
five pups per litter in the report by Ahima et al. and eight to
nine pups per litter in the present study.
To examine whether premature leptin surge is associated
with pronounced weight gain in UN offspring on an HFD, we
induced premature leptin surge in NN offspring by exogenous
administration of leptin from day 5.5 to day 10.5 of life. In addi-
tion to the significant elevation of endogenous leptin surge ob-
served in UN offspring compared to NN offspring demon-
strated in Figure 3A, serum leptin concentrations at 5.5 days
of age in UN offspring were also higher than those in NN off-
spring in another series of experiments (data not shown).
Therefore, we determined the period of exogenous leptin ad-
ministration as above. Serum leptin concentration after subcu-
taneous leptin treatment in pups at 5.5 days of age reached its
peak (3955 ± 445 ng/ml) at 2 hr after injection and returned to
levels similar to vehicle-treated pups by 8 hr after injection.
During the 6 days of daily leptin treatment, NN offspring treated
with leptin tended to gain less weight compared to vehicle-
treated groups, but the difference was not significant. This is
consistent with previous findings that leptin does not exert its373
A R T I C L EFigure 3. Premature onset of leptin surge in UN offspring as a trigger of exagger-
ated weight gain on an HFD
A) Serum leptin concentrations and (B) leptin mRNA expression in subcutaneous
adipose tissue during neonatal development. Both male and female pups were
assayed without discrimination. Note the earlier occurrence of leptin surge in
UN offspring.
C) Body weight changes of NN offspring during neonatal leptin or vehicle treatment.
Average body weights of both male and female pups are shown. n = 20–22.
D) Exaggerated weight gain on an HFD in NN offspring with early neonatal leptin
treatment. HFD was started at 9 weeks of age.
E) Plasma leptin concentrations at 17 weeks of age in NN offspring with or with-
out early neonatal leptin treatment.
F) Average daily calorie intake from 9 to 17 weeks of age on an RCD or HFD.
Dark and light orange lines (C and D) and columns (E and F) indicate offspring
with neonatal leptin treatment. Neo-Lep: offspring with neonatal leptin treatment;
Neo-Veh: offspring with neonatal vehicle treatment. *p < 0.05 versus control ;
A.U.: arbitrary units. n = 8–10 for each column or line except for (C). Error bars
represent SEM.anorectic effect until the third week of life (Mistry et al., 1999;
Proulx et al., 2002). They caught up in growth by the time of
weaning (Figure 3C). Body weight and fat mass of leptin-
treated NN offspring were similar to those of vehicle-treated
NN offspring on an RCD thereafter (Figure 3D for body weight
and 0.36 ± 0.05 versus 0.31 ± 0.04 g for subcutaneous adipose
mass). On an HFD, however, leptin-treated NN offspring devel-
oped accelerated weight gain and adiposity compared to vehi-
cle-treated groups (Figure 3D for body weight and 2.02 ± 0.11374versus 1.63 ± 0.17 g for subcutaneous adipose mass). An obe-
sity-prone phenotype of offspring with neonatal leptin treat-
ment was confirmed in an additional two independent experi-
ments. The serum leptin levels in NN offspring with neonatal
leptin treatment were significantly increased compared to vehi-
cle-treated groups during the development of diet-induced
obesity (Figure 3E). Calorie intake of leptin-treated NN offspring
was similar to that of vehicle-treated groups on an HFD (Figure
3F), implying an involvement of decreased energy expenditure
in the aggravation of HFD-induced obesity. Thus, as NN off-
spring with neonatal leptin treatment were phenotypically indis-
tinguishable from UN offspring, premature onset of leptin surge
is causally related to pronounced obesity in UN offspring on
an HFD.
Leptin resistance in offspring with exposure
to premature leptin surge
Resistance to the weight-reducing effect of leptin is a feature
of obesity with hyperleptinemia (Flier, 2004; Friedman, 2000). It
has been described that high-calorie diet induces obesity with
leptin resistance by at least two different mechanisms (El-
Haschimi et al., 2000), an impairment of leptin transfer through
the blood-brain barrier (BBB) and/or a disturbed signal transfer
in the hypothalamus. To examine the response to exogenous
leptin administration in UN and NN offspring, we performed
an acute intraperitoneal (i.p.) or intracerebroventricular (i.c.v.)
injection of leptin in UN and NN offspring on an RCD at 8 to
10 weeks of age when they were of similar weight. Animals
used in this section are a new set of mice not used in other
studies. No significant difference was observed in serum leptin
levels between UN and NN offspring 2 hr after i.p. injection of
leptin (74.0 ± 13.9 versus 72.2 ± 6.1 ng/ml; n = 8) in a prelimi-
nary experiment. In NN offspring, body-weight increase was
significantly suppressed 12 hr after i.p. leptin treatment (Figure
4A; p < 0.05), whereas no such effects were observed in UN
offspring. In this study, i.p. injection of leptin stimulated phos-
phorylation of signal transducer and activator of transcription
3 (STAT3), an intracellular signaling mediator of leptin action
(El-Haschimi et al., 2000), in the hypothalamus of NN offspring,
but not of UN offspring (Figure 4B). Then we detected c-Fos
positive cells, i.e., activated neurons (Elmquist, 2001), after i.p.
injection of leptin. The number of c-Fos-positive cells was
smaller in UN offspring than in NN offspring in the hypothala-
mic arcuate nucleus (ARH; Figure 4C) and paraventricular hy-
pothalamus (PVH) nuclei mediating hypothalamic leptin signal-
ing (Schwartz et al., 2000; Wilding, 2002; Figure 4D). By
contrast, the response to i.c.v. injection of leptin in UN off-
spring was not blunted with regard to body weight (Figure 4E)
and STAT3 phosphorylation in the hypothalamus (Figure 4F)
compared to NN offspring. We also obtained essentially the
same data in NN offspring treated neonatally with leptin (Fig-
ures 4G and 4H). These observations suggest impaired brain
leptin transport (Caro et al., 1996) in UN offspring as well as in
NN offspring treated neonatally with leptin. This is supported
by a significant reduction in mRNA expression of the short-
form leptin receptor, Ob-Ra, which is suggested to play a role
in the transport of leptin across the BBB (Hileman et al., 2002)
in the hypothalamus of UN offspring (1.23 ± 0.16 arbitrary units
[AU]; n = 7) compared to that of NN offspring (2.09 ± 0.15 AU;
n = 10; p < 0.01). It is likely that a premature leptin surge in UN
offspring leads to resistance to peripherally administered lep-CELL METABOLISM : JUNE 2005
Premature leptin surge in development of obesityFigure 4. Resistance to peripheral leptin in adult UN and NN offspring with neo-
natal leptin treatment
A) Body weight changes following intraperitoneal (i.p.) leptin administration in UN
and NN offspring.
B) Phosphorylated STAT3 in the entire hypothalamus after i.p. leptin admin-
istration.
C) The number of c-Fos-positive cells in arcuate nucleus of the hypothalamus
after acute leptin administration at 10 weeks of age. Mean number of cells with
c-Fos-like immunoreactivity after saline vehicle treatment was 9.5 ± 0.7 (n = 4)
with no remarkable difference between UN and NN offspring.
D) The number of c-Fos-positive cells in paraventricular hypothalamus in the
same brain tissues as in (C). Mean number of cells with c-Fos-like immunoreac-
tivity after saline vehicle treatment was 8.5 ± 0.7 (n = 4) with no remarkable
difference between UN and NN offspring
E) Body-weight changes following intracerebroventricular (i.c.v.) leptin admin-
istration.
F) Phosphorylated STAT3 in the entire hypothalamus after i.c.v. leptin admin-
istration.
G) Body-weight changes following i.p. leptin administration in NN offspring with
neonatal leptin or vehicle treatment.
H) Body-weight changes following i.c.v. leptin administration in NN offspring with
neonatal leptin or vehicle treatment.
All procedures were performed at 8–10 weeks of age. Lep: acute leptin admin-
istration; Veh: acute vehicle administration; Neo-Lep: neonatal leptin treatment;
Neo-Veh: neonatal vehicle treatment; n.s.: not significant; n = 8–12; A.U.: arbitrary
unit. Error bars represent SEM.CELL METABOLISM : JUNE 2005tin, accompanied by impaired leptin transport to the brain.
However, neither UN offspring nor NN offspring with neonatal
leptin treatment developed obesity on an RCD, suggesting that
as-yet-unidentified compensatory mechanisms are operative.
On an HFD, both UN offspring and NN offspring with neona-
tal leptin treatment showed hyperleptinemia concomitant with
pronounced obesity, indicating that they are less sensitive to
circulating leptin than NN offspring without neonatal leptin
treatment. It remains to be elucidated how resistance to circu-
lating leptin might be involved in the pronounced weight gain
on a high fat diet in the present study.
The hypothalamus is responsible for the development
of obesity
Since the ARH plays a critical role in the central regulation of
thermogenesis, we chemically injured the ARH of UN and NN
offspring by neonatal administration of monosodium glutamate
(MSG; Olney, 1969), which is known to induce obesity through
reduced thermogenesis (Tokuyama and Himms-Hagen, 1986).
No significant difference in body weight was observed between
MSG-treated UN offspring and MSG-treated NN offspring on a
HFD (Figure 5A), implying that the hypothalamic area damaged
by MSG (i.e., ARH) is responsible for pronounced weight gain
in UN offspring on a HFD. Nevertheless, the possibility cannot
be fully neglected that rapid body-weight gain induced by hy-
pothalamic ablation with MSG obscures the augmentation of
diet-induced obesity after neonatal exposure to premature lep-
tin surge. In this study, we found that in both wild-type UN
offspring with endogenous premature leptin surge and NN off-
spring treated neonatally with exogenous leptin, the density of
nerve terminals containing neuropeptide Y (NPY) or cocaine
and amphetamine-regulated transcript (CART) was increased,
in PVH that receives the downstream leptin signaling from ARH
(Schwartz et al., 2000; Wilding, 2002; Figures 5B and 5C).
These alterations were preserved even after pronounced
weight gain on an HFD (data not shown). Although many ani-
mal and human studies implicate that CART is involved in ther-
mogenesis and has an inhibitory effect against development of
obesity (Hunter et al., 2004), there is some controversy about
anorexigenic effect of CART neuropeptide (Kong et al., 2003).
It will be interesting to elucidate the possible relationship be-
tween such hypothalamic structural changes and the develop-
ment of pronounced HFD-induced obesity.
Proulx et al. (2002) revealed that leptin increased proopio-
melanocortin (POMC) expression and decreased NPY and lep-
tin-receptor expression in the hypothalamus in the developing
rat. Moreover, Bouret et al. (2004a) demonstrated that leptin
promotes neural projections from ARH to other hypothalamic
nuclei including PVH. These findings suggest that premature
onset or augmentation of neonatal leptin surge might induce
organic and/or functional alterations in the developing hypo-
thalamus.
Catch-up growth is associated with adulthood obesity in mice
(Ozanne and Hales, 2004) as well as in humans (Stettler et al.,
2002). The present study demonstrated that onset of leptin
surge is advanced in UN offspring during the catch-up period
and that this premature leptin surge contributes to a conver-
sion to an obesity-prone phenotype in UN offspring. Impair-
ment of leptin transfer through the BBB in the hypothalamus
may be linked with this phenotypic conversion in wild-type off-
spring. In addition, the hypothalamic nuclei are responsible for375
A R T I C L EFigure 5. Involvement of the hypothalamic regulation in the exaggeration of diet-
induced obesity in offspring with intrauterine undernutrition
A) Body-weight changes of UN and NN offspring with neonatal monosodium
glutamate (MSG) treatment. Mice were fed an RCD or an HFD from 9 weeks of
age. n = 10–12.
B) Increased nerve terminal densities of NPY in PVH of UN offspring as well as
NN offspring with neonatal leptin treatment.
C) Increased nerve terminal densities of CART in PVH of UN offspring as well as
NN offspring with neonatal leptin treatment.
Figures in (B) and (C) are representative of at least four mice in each study group.
Neo-Lep: neonatal leptin treatment; Neo-Veh: neonatal vehicle treatment. Scale
bar, 20 m. Error bars represent SEM.the onset of pronounced adiposity on an HFD, as demon-
strated in MSG-treated UN offspring. Altered hypothalamic
neural structure, including adipostatic and counter-regulatory
signals, may be involved in the programming of increased adi-
posity by premature leptin surge. We also observed that in-
creased adiposity on an HFD was programmed by exoge-
nously treated premature leptin surge even in the absence of
leptin signal in ob/ob background (S.Y., H.I., and N.S., unpub-
lished data). This implies that altered hypothalamic neural
structure in offspring with exposure to premature leptin surge
might be involved in the programming of increased adiposity
in addition to a decrease in sensitivity to circulating leptin.
Epidemiological evidence suggests that intrauterine under-
nutrition predisposes humans to obesity and metabolic syn-
drome later in life (Godfrey and Barker, 2000; Ravelli et al.,
1976; Wajchenberg, 2000). The “fetal programming” hypothe-
sis postulates that undernutrition in utero causes permanent376changes in structure, physiology, and metabolism to adapt to
restricted nutritional supply (thrifty phenotype; Godfrey and
Barker, 2000). When the nutritional supply is excessive (e.g.,
exposure to a high-calorie diet in Western life style), such thrifty
traits by fetal programming become maladaptive, that is, con-
tribute to the development of obesity and metabolic syndrome
(Wells, 2003). Currently, neonates born small for gestational
age are increasing in number (Ananth et al., 2004). They show
a transient overshoot in plasma leptin levels during the catch-
up period (Jaquet et al., 1999). The present findings suggest
the possibility that premature rise in plasma leptin levels is in-
volved in fetal programming in these neonates and contributes
to obesity and subsequent metabolic disorders after exposure
to a high-calorie diet.
In conclusion, this study demonstrates that the timing of
neonatal leptin surge determined by fetal nutrition contributes
to the development of accelerated obesity in later life. This
study also highlights the leptin surge as a target for therapeutic
intervention in the developmental origins of health and disease.
Experimental procedures
Development of a mouse model of undernutrition in utero
Pregnant C57Bl/6 mice were purchased 6.5 days postcoitum (d.p.c.) from
Japan Central Laboratories for Experimental Animals (Tokyo, Japan) and
were divided into two groups 10.5 d.p.c. Dams were individually housed
with free access to water during 14 hr/10 hr light/dark cycles (0700 hr, 2100
hr) in a specific-pathogen-free facility. The daily food supply of one group
was restricted to 70% of the food consumed by the other group, fed ad
libitum, based on the data of the previous day, from 10.5 d.p.c. to the day
of delivery of the pups. Dams in the food-restriction group were given 2.5
g of extra food supply in the evening of 18.5 d.p.c., just before the initiation
of parturition, to prevent them from eating their own pups. Litter size was
examined on 1.5 days after delivery. Offspring from dam with less than 8
pups or larger than 10 pups were excluded from the study. To control litter
size to 8 or 9 per dam, pups were culled or moved to other dams and
were fostered until weaning, depending on the total pup numbers in every
experimental course. Pups were weaned on to RCD at 21.5 days of age.
Only male offspring were used in any experiments after weaning from dams.
Each experimental group in all experiments consists of offspring from at
least three litters. Caloric intakes by offspring after weaning were measured
in groups (three to four per cage) twice a week. All experimental procedures
were approved by the Animal Research Committee, Graduate School of
Medicine, Kyoto University.
High fat diet (HFD)
At 9 weeks of age, HFD (containing 60% lipid by calorie mainly by lard,
formula D12492, Research Diets Inc., New Brunswick, NJ, http://www.
researchdiets.com/formulas/item/dio.htm) or RCD (containing 12% lipid and
20.0% protein by calorie, 3.44 kcal/g, CLEA Japan Inc., Tokyo, Japan) was
supplied to NN and UN offspring.
Energy metabolism analysis
Body temperature was determined by measuring rectal core temperature
25 times with a digital thermometer (TD-320, Shibaura Electronics Co. Ltd.,
Tokyo, Japan). Oxygen (O2) consumption and CO2 production in the resting
state were measured with an O2/CO2 metabolism measuring system (Model
MK-5000, Muromachikikai, Tokyo, Japan; Nakagawa et al., 2000).
Glucose metabolism
Glucose tolerance test was performed by i.p. administration of glucose (1.5
mg/g body weight) after overnight fasting. Insulin sensitivity was examined
by i.p. administration of insulin (0.75 mU/g body weight) after overnight
fasting. Blood glucose concentrations were determined by Glutest Ace R
(Sanwa Kagaku Kenkyusho Co. Ltd., Nagoya, Japan).CELL METABOLISM : JUNE 2005
Premature leptin surge in development of obesityBlood sample assays
Serum concentrations of triglyceride, total cholesterol, and HDL cholesterol
were determined using the Fuji DRI-CHEM system (Fuji Photo Film Co. Ltd.,
Tokyo, Japan). Serum leptin concentrations were determined by Mouse
Leptin ELISA (R&D Systems, Inc., Minneapolis, Minnesota).
Quantitative RT-PCR analysis
Total RNA from subcutaneous adipose tissue was extracted as previously
described (Masuzaki et al., 1997). Gene expression of leptin was deter-
mined by quantitative RT-PCR using TaqMan Probes (Applied Biosystems,
Foster City, California), according to the manufacturer’s recommendation.
Primers and fluorescent probe for leptin are as follows: forward, ttcacacacg
cagtcggtatc; reverse, tggtccatcttggacaaactca; TaqMan Probe, tgaagtccaag
ccagtgaccctctgc. Those for short-form leptin receptor (Ob-Ra) are as fol-
lows: forward, ctgaatttccaaaagagaacgga, reverse, ggaagttggtagattgggttc
atct, TaqMan Probe, tgaagtctctcatgaccact. Ribosomal RNA contents or
GAPDH mRNA expression was used as an internal control.
Neonatal leptin or MSG treatment
Leptin (2.5 g/g body weight/day) (kind donation from Amgen Inc., Thou-
sand Oaks, California) or vehicle saline was subcutaneously administered
to NN offspring daily from 5.5 to 10.5 days of age. Monosodium glutamate
(MSG; 2 mg/g body weight/day) was subcutaneously administered to NN
and UN offspring from 1.5 to 5.5 days of age (Olney, 1969).
Acute leptin administration to adult offspring
Leptin was administered i.p. (2.5 g/g body weight) or i.c.v. (0.5 g/mouse;
Aizawa et al., 2000) to NN and UN offspring at 1900 hr at 8 weeks of age,
and body-weight changes and food consumption were measured for the
next 12 hr. The i.c.v. placement technique was confirmed by dye injection
in preliminary experiment. Additionally, scanty backflow was observed after
each injection.
Mice with confirmed leptin resistance or leptin sensitivity in UN offspring
and NN offspring, respectively, by a single dose of i.p. leptin treatment were
used for the following phosphorylated STAT3 and c-Fos immunoreactivity
experiment.
Detection of phosphorylated STAT3 in the hypothalamus
Phosphorylated STAT3 protein in the entire hypothalamus of UN offspring
was measured 30 min after acute i.p. (1.5 g/g body weight) or i.c.v. (0.2
g/mouse) administration of leptin at 10 weeks of age. Protein extraction
was performed as previously described (Itoh et al., 1998). An ECL Advance
kit (Amersham Bioscience Corp., Piscataway, New Jersey) was used with
anti-mouse pSTAT3 antibody (1:1,000, overnight; Cell Signaling Technology,
Beverly, Massachusetts) and anti-rabbit IgG antibody with HRP (1:20,000,
1 hr; Cell Signaling Technology, Beverly, Massachusetts).
Detection of activated neurons by c-Fos immunoreactivity
To prevent stress-induced c-Fos expression, intraperitoneal cannulas were
placed 7 days before treatment. Leptin (0.5 g/g body weight) or vehicle
saline was gently administered through the i.p. cannulas after 2 hr of fasting
at 10 weeks of age. Peak serum leptin levels were observed at 15 min after
the i.p. leptin injection on preliminary examination (data not shown). The
entire hypothalamus was sampled 135 min after the treatment and pro-
cessed for immunohistochemistry as described previously (Yamamoto et
al., 2002), using rabbit polyclonal antibody against c-Fos (1:50,000, 6 days
at 4°C; Oncogen Research Products, San Diego, California). The number of
c-Fos-positive cells in ARH (at −1.46 mm behind the bregma) and PVH (at
−1.06 mm behind the bregma) were counted in approximately the same
plane by a researcher who was blind with respect to the treatment. The
distance of sections behind bregma was determined according to the atlas
of mouse brain (Paxinos and Franklin, 2001).
Neuroanatomical analysis
Immunohistochemical analysis of the hypothalamus was performed as
above. The antibodies used were anti-NPY antibody (1:5,000, 6 days at
4°C; Chemicon Internatinal, Temecula, California) or anti-CART antibody
(1:10,000, 6 days at 4°C; Phoenix Pharmaceuticals Inc., Belmont, Cali-
fornia). Mice were sacrificed at 12 weeks of age. The NPY and CART
immunostaining was examined on the sections at −1.06 mm behind theCELL METABOLISM : JUNE 2005bregma. But we compared CART immunostaining on the sections at −0.82
mm behind the bregma in NN offspring with neonatal vehicle or leptin treat-
ment because we did not obtain exact matches at −1.06 mm behind the
bregma.
Statistics
Data are expressed as mean ± SEM and the statistical significance of differ-
ences in mean values was assessed using Student’s t test or analysis of
variance (ANOVA) with Fisher’s protected least-significant-difference test,
as appropriate. Differences among means were considered significant at
values of p < 0.05.
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